首页> 外文期刊>Human Molecular Genetics >APC mutations in FAP-associated desmoid tumours are non-random but not ‘just right’
【24h】

APC mutations in FAP-associated desmoid tumours are non-random but not ‘just right’

机译:与FAP相关的胶质瘤中的APC突变是非随机的,但并非“恰到好处”

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Analysis of APC mutations in colonic and duodenal tumours from familial adenomatous polyposis (FAP) patients has shown that the site of the first hit, the germline mutation, can predict the type and position of the somatic mutation or ‘second hit’. The two APC mutations are selected on the basis of a ‘just right’ level of beta-catenin signalling in intestinal tumours achieved through retention of some of the seven 20-amino-acid beta-catenin degradation repeats. Desmoids are a life threatening extra-colonic manifestation in FAP patients. These aggressive tumours of mesenchymal origin are, at present, poorly characterized in terms of mutational APC spectra. We have investigated somatic mutations in the largest cohort of FAP-associated desmoids to date, and combined our results with previously published data. Somatic mutations were found to occur non-randomly and the position of the germline mutation shown to be a major determinant of the somatic mutation, a characteristic shared with intestinal tumours from FAP patients. In contrast to colonic polyps, loss of heterozygosity in desmoids involved deletion rather than mitotic recombination. While tumours from the colorectum and upper gastrointestinal tract usually retain one to two and three to four beta-catenin degradation repeats, respectively, most desmoids preferentially retain two repeats (P < 0.001, χ2 test). In addition, most desmoids with two APC hits (87%, 26/30) had one mutated allele with no 20-amino acid repeats (P < 0.001). This feature, unique among FAP tumours, indicates that a mutation deleting all repeats from one allele may be an important component in maintaining appropriate levels of beta-catenin signalling levels in desmoid tumour cells.
机译:对来自家族性腺瘤性息肉病(FAP)患者的结肠和十二指肠肿瘤中的APC突变进行的分析表明,首次击中的部位,即生殖系突变,可以预测体细胞突变或“第二次击中”的类型和位置。通过保留七个七个20个氨基酸的β-catenin降解重复序列中的一部分来实现肠道肿瘤中“β-catenin”信号的“正当”水平选择两个APC突变。在FAP患者中,类胶质是威胁生命的结肠外表现。目前,就间充质起源的这些侵袭性肿瘤而言,其突变APC光谱的特征很差。我们已经研究了迄今为止最大的FAP相关类胶体队列中的体细胞突变,并将我们的结果与以前发表的数据相结合。发现体细胞突变是非随机发生的,种系突变的位置显示是体细胞突变的主要决定因素,这一特征与FAP患者的肠道肿瘤共有。与结肠息肉相反,类胶体中杂合性的丧失涉及缺失而不是有丝分裂重组。大肠和上消化道肿瘤通常分别保留1至2个和3至4个β-catenin降解重复序列,而大多数类胶质瘤优先保留2个重复序列(P <0.001,χ 2 测试)。此外,大多数具有两次APC命中的类胶体(87%,26/30)具有一个突变的等位基因,没有20个氨基酸的重复(P <0.001)。这一特征在FAP肿瘤中是独一无二的,表明从一个等位基因中删除所有重复的突变可能是维持类胶质瘤细胞中适当水平的β-catenin信号传导的重要组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号